Novartis AG Common Stock (NVS)
EBITDA Growth
-2.30%
Quarterly · Period ending:
NVS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-2.30%period ending
Latest reported-2.30%period ending
NVS Quarterly EBITDA YoY % (-22.06% → -2.30%)
Year-over-year change
High-resolution chart · PNG
NVS ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -2.9% | |
| -22.0642% |